CH INNOVATION (01217) net asset value per share at the end of September was approximately HK$0.043.
CH INNOVATION (01217) announced that as at 30 September 2026, the unaudited net asset value per share of the Company was approximately HK$0.043.
CH INNOVATION (01217) announced that as at September 30, 2026, the unaudited net asset value per share of the company was approximately HK$0.043.
Related Articles
CHINA RISUN GP (01907) repurchased 257,000 shares for HK$408,600 on October 13.
CHAOJU EYE CARE (02219) repurchased 92,000 shares for HK$219,900 on October 13.
ASCLETIS-B (01672) repurchased 200,000 shares for HK$1.3428 million on October 13.
CHINA RISUN GP (01907) repurchased 257,000 shares for HK$408,600 on October 13.
CHAOJU EYE CARE (02219) repurchased 92,000 shares for HK$219,900 on October 13.
ASCLETIS-B (01672) repurchased 200,000 shares for HK$1.3428 million on October 13.
